Preoperative Characteristics
DISEASE
Between December 2020 and July 2022, 18 patients were enrolled in the study. The median age at surgery was 69 years (interquartile range [IQR] 58–71.5), and 11 (61%) were females. Half of the cohort had clinically nodal positive disease, and 11 (61%) patients underwent neoadjuvant therapy. Neoadjuvant therapy regimens were FLOT in five cases, mFOLFOXIRI in four cases, and tremelimumab and durvalumab in two cases. Preoperative characteristics are summarized in Table Preoperative characteristics (stages I–II)Data are number (percentage) and median (interquartile range)